Antimutagenic activity of afobazole in various regimens of treatment

Bulletin of Experimental Biology and Medicine

Volumn 130, Issue 11, 2000, Pages 1077-1079

  Zhanataev, A K ^a   Durnev, A D ^a   Seredin, S B ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

2 mercaptobenzimidazole; Afobazole; Antimutagen; Chromosome aberrations; Mice

Indexed keywords

2 BENZIMIDAZOLETHIOL DERIVATIVE; AFOBAZOLE; CYCLOPHOSPHAMIDE; DIOXIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; MALE; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; TREATMENT PLANNING;

ANIMALIA;

ANIMALS; ANTIMUTAGENIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIOXIDANTS; BENZIMIDAZOLES; CHROMOSOME ABERRATIONS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MORPHOLINES; OXIDANTS; QUINOXALINES;

EID: 0035036208     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02688183     Document Type: Article

References (6)